Histologic Assessment and Prognostic Factors of Malignant Pleural Mesothelioma Treated with Extrapleural Pneumonectomy
Overview
Authors
Affiliations
We studied 56 cases of malignant pleural mesothelioma (MPM) treated with extrapleural pneumonectomy (EPP). The slides from the EPP specimens were reviewed, and tumors were classified with the guidance of the World Health Organization classification of pleural tumors. Agreement between the histologic type from the EPP review and the diagnostic procedure (DP) reports was evaluated. Histologic and clinical parameters were also correlated with clinical outcome. There was a significant disagreement (P = .0001) between the histologic type in the DP reports and the EPP specimen review. The histologic type from the DP was associated with disease-specific survival (DSS); however, the histologic type from the EPP specimen was not associated with survival. Postoperative treatment was associated with DSS and with recurrence-free survival. Our study confirms that in many cases, final histopathologic typing of MPM is influenced by complete surgical resection and that initial biopsy should be carefully weighed in the treatment stratification.
Case report: Imaging of adrenal adenomatoid tumors: reports of two cases and review of literature.
Wu Y, Hu D, Cui M, Liu Y, Zhou X, Zhai D Front Oncol. 2024; 14:1435143.
PMID: 39429478 PMC: 11486722. DOI: 10.3389/fonc.2024.1435143.
Chirieac L, Hung Y, Foo W, Hofer M, VanderLaan P, Richards W Cancer. 2019; 125(23):4164-4171.
PMID: 31390057 PMC: 7341068. DOI: 10.1002/cncr.32416.
Review of malignant pleural mesothelioma survival after talc pleurodesis or surgery.
Taioli E, van Gerwen M, Mihalopoulos M, Moskowitz G, Liu B, Flores R J Thorac Dis. 2018; 9(12):5423-5433.
PMID: 29312753 PMC: 5756994. DOI: 10.21037/jtd.2017.11.55.
Novel immunotherapy clinical trials in malignant pleural mesothelioma.
Tano Z, Chintala N, Li X, Adusumilli P Ann Transl Med. 2017; 5(11):245.
PMID: 28706913 PMC: 5497103. DOI: 10.21037/atm.2017.03.81.
Reproducibility of histological subtyping of malignant pleural mesothelioma.
Brcic L, Jakopovic M, Brcic I, Klaric V, Milosevic M, Sepac A Virchows Arch. 2014; 465(6):679-85.
PMID: 25300229 DOI: 10.1007/s00428-014-1664-9.